VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25623N0174
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,684
Award facts
- Contract value 96% obligated
-
- $21,684.00 Current, with exercised options
- $22,525.28 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$22,525 | |
| Original award | $44,209 |
About this award
Roche Diagnostics Corporation received a $22,525.28 Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network 16 (VISN 16) for point-of-care whole blood glucose testing equipment and supplies. This contract, effective October 1, 2022 through September 30, 2023, operates under a firm fixed-price structure and is derived from Roche's parent GSA Schedule contract for In Vitro Diagnostics, Reagents, and Tests (FSS-65-VII). The award carries no set-aside designation and was competitively awarded to support veterans' healthcare diagnostic capabilities at the performance location in Castleton, Indiana.
As a leading provider of diagnostic solutions to federal healthcare systems, Roche Diagnostics Corporation supplies comprehensive point-of-care testing devices and associated reagents across multiple Veterans Affairs facilities and Defense Health Agency locations. This VISN 16 BPA call represents continued procurement of essential glucose monitoring equipment needed to support clinical operations within the veterans healthcare network. The contract leverages Roche's established GSA schedule pricing and delivery mechanisms, enabling efficient acquisition of diagnostic consumables and equipment to meet ongoing medical testing requirements for the veteran population.
Quick answers
Who was awarded contract 36C25623N0174?
36C25623N0174 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25623N0174 worth?
The government has obligated $21,684 on 36C25623N0174. Its potential value, with all options, is $22,525.
Is contract 36C25623N0174 an order under another contract?
Yes. 36C25623N0174 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25623N0174 competed?
The extent of competition for 36C25623N0174 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award